Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
oleh: Alexander Egeberg, Joseph F. Merola, Knut Schäkel, Luis Puig, Patrick D. Mahar, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster, Christopher Schuster, Christopher E. M. Griffiths
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2023-03-01 |
Deskripsi
Subjek
moderate-to-severe psoriasis; type 2 diabetes; prediabetes; ixekizumab; obesity